Picture of Gland Pharma logo

GLAND — Gland Pharma News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Gland Pharma Meets Q3 Consol Net Profit View

Feb 3 (Reuters) - Gland Pharma Ltd  GLAD.NS :
    * Q3 CONSOL NET PROFIT 2.05 BILLION RUPEES; IBES EST. 2.04
BILLION
RUPEES
    * Q3 CONSOL REVENUE FROM OPERATIONS 13.84 BILLION RUPEES;
IBES
EST. 15.69 BILLION RUPEES

Further company coverage:  GLAD.NS 

 ((Reutersbriefs@thomsonreuters.com;))

Recent news on Gland Pharma

See all news